ProShare Advisors’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-14,375
| Closed | -$43K | – | 2217 |
|
|
2022
Q1 | $43K | Sell |
14,375
-3,383
| -19% | -$10.1K | ﹤0.01% | 2124 |
|
|
2021
Q4 | $80K | Buy |
17,758
+1,234
| +7% | +$5.56K | ﹤0.01% | 2231 |
|
|
2021
Q3 | $80K | Sell |
16,524
-3,784
| -19% | -$18.3K | ﹤0.01% | 1937 |
|
|
2021
Q2 | $139K | Buy |
20,308
+2,337
| +13% | +$16K | ﹤0.01% | 2232 |
|
|
2021
Q1 | $127K | Buy |
17,971
+1,264
| +8% | +$8.93K | ﹤0.01% | 2136 |
|
|
2020
Q4 | $105K | Buy |
+16,707
| New | +$105K | ﹤0.01% | 1982 |
|
|
2019
Q4 | – | Sell |
-12,454
| Closed | -$54K | – | 1809 |
|
|
2019
Q3 | $54K | Sell |
12,454
-416
| -3% | -$1.8K | ﹤0.01% | 1595 |
|
|
2019
Q2 | $51K | Sell |
12,870
-1,547
| -11% | -$6.13K | ﹤0.01% | 1572 |
|
|
2019
Q1 | $77K | Buy |
14,417
+205
| +1% | +$1.1K | ﹤0.01% | 1592 |
|
|
2018
Q4 | $73K | Sell |
14,212
-2,579
| -15% | -$13.2K | ﹤0.01% | 1506 |
|
|
2018
Q3 | $163K | Sell |
16,791
-633
| -4% | -$6.15K | ﹤0.01% | 1626 |
|
|
2018
Q2 | $178K | Sell |
17,424
-433
| -2% | -$4.42K | ﹤0.01% | 1634 |
|
|
2018
Q1 | $232K | Sell |
17,857
-732
| -4% | -$9.51K | ﹤0.01% | 1463 |
|
|
2017
Q4 | $333K | Buy |
18,589
+1,315
| +8% | +$23.6K | ﹤0.01% | 1330 |
|
|
2017
Q3 | $434K | Buy |
17,274
+1,083
| +7% | +$27.2K | ﹤0.01% | 1015 |
|
|
2017
Q2 | $390K | Buy |
16,191
+2,005
| +14% | +$48.3K | ﹤0.01% | 1043 |
|
|
2017
Q1 | $273K | Sell |
14,186
-3,705
| -21% | -$71.3K | ﹤0.01% | 1285 |
|
|
2016
Q4 | $276K | Buy |
+17,891
| New | +$276K | ﹤0.01% | 1426 |
|